Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen

US Patent 9845351 · Granted Dec 19, 2017

Assignee

Inventors

View full patent text on Google Patents →